Imperial College London
Alternate

ProfessorFanChung

Faculty of Medicine, National Heart & Lung Institute

Professor of Respiratory Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 7954f.chung Website

 
 
//

Assistant

 

Miss Carolyn Green +44 (0)20 7594 7959

 
//

Location

 

227BGuy Scadding BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Liu:2023:10.1016/j.lanwpc.2023.100826,
author = {Liu, Z and Qin, R and Hu, X-J and Liu, L-J and Xu, S-Q and Shi, G-C and Zhou, H and Bai, J and Zhang, C-M and Qi, Y and Zhou, W and Lan, S-H and Tong, J and Su, T-S and Wang, Q and Yang, X-Y and Sun, D-J and Zhu, L-M and Chen, X-Y and Chen, H and Xie, Y-P and Xiao, Z-H and Chen, Y-B and Zhao, B and Wu, Q-G and Chen, W-L and Li, D-Y and Liu, H and Cheng, A-Q and Cui, Z-Y and Zhao, L and Li, J-X and Wei, X-W and Zhou, X-M and Su, Z and Chung, KF and Chen, Z-M and Xiao, D and Wang, C},
doi = {10.1016/j.lanwpc.2023.100826},
journal = {Lancet Reg Health West Pac},
title = {Real-world tobacco cessation practice in China: findings from the prospective, nationwide multicenter China National Tobacco Cessation Cohort Study (CNTCCS).},
url = {http://dx.doi.org/10.1016/j.lanwpc.2023.100826},
volume = {39},
year = {2023}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BACKGROUND: Tobacco cessation is proven to be the most effective and cost-effective strategy for smokers to reduce their risk of smoking-related disease and premature death. Providing effective, efficient, safe, and patient-centred tobacco cessation treatment to reach those who need them is a significant challenge. To date, only a few nationwide studies in China have assessed the overall clinical care practice and treatment outcome of tobacco cessation. METHODS: This a prospective, nationwide, multicenter, cohort study covering all Eastern China, Northwest China, Central China, North China, Southwest China, Northeast China, and South China. Participants who were current smokers aged 18-85 years attending clinic for smoking cessation were included. All the participants were treated with 3-month cessation treatment and followed up for 3 months. Data were collected prospectively using online system. The primary outcome was 7-day point abstinence rate at 24 weeks, validated biochemically by an expired carbon monoxide level of less than 10 ppm. The participants lost to follow-up or not providing validation were included as non-abstainers. FINDINGS: A representative sample of 3557 participants were recruited and 2943 participants were included into this analysis. These participants had mean age of 53.05 years, and 94.8% were males, with 75.8% showing symptoms of tobacco dependence. A total of 965 (32.8%) participants were treated with Bupropion + behavioural counselling, followed by 935 (31.8%) with behavioural counselling, 778 (26.4%) with Varenicline + behavioural counselling, 135 (4.6%) with alternative treatments + behavioural counselling, and 130 (4.4%) with nicotine replacement therapy (NRT) + behavioural counselling. After 3-month treatment and 3-month follow-up, 21.74% of the participants quit smoking at 24 weeks. In the multivariable-adjusted analyses, quitting smoking was significantly associated with female, higher socioe
AU  - Liu,Z
AU  - Qin,R
AU  - Hu,X-J
AU  - Liu,L-J
AU  - Xu,S-Q
AU  - Shi,G-C
AU  - Zhou,H
AU  - Bai,J
AU  - Zhang,C-M
AU  - Qi,Y
AU  - Zhou,W
AU  - Lan,S-H
AU  - Tong,J
AU  - Su,T-S
AU  - Wang,Q
AU  - Yang,X-Y
AU  - Sun,D-J
AU  - Zhu,L-M
AU  - Chen,X-Y
AU  - Chen,H
AU  - Xie,Y-P
AU  - Xiao,Z-H
AU  - Chen,Y-B
AU  - Zhao,B
AU  - Wu,Q-G
AU  - Chen,W-L
AU  - Li,D-Y
AU  - Liu,H
AU  - Cheng,A-Q
AU  - Cui,Z-Y
AU  - Zhao,L
AU  - Li,J-X
AU  - Wei,X-W
AU  - Zhou,X-M
AU  - Su,Z
AU  - Chung,KF
AU  - Chen,Z-M
AU  - Xiao,D
AU  - Wang,C
DO  - 10.1016/j.lanwpc.2023.100826
PY  - 2023///
TI  - Real-world tobacco cessation practice in China: findings from the prospective, nationwide multicenter China National Tobacco Cessation Cohort Study (CNTCCS).
T2  - Lancet Reg Health West Pac
UR  - http://dx.doi.org/10.1016/j.lanwpc.2023.100826
UR  - https://www.ncbi.nlm.nih.gov/pubmed/37927997
VL  - 39
ER  -
Download